Literature DB >> 12478617

Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.

Agata Matejuk1, Abigail C Buenafe, Jami Dwyer, Atsushi Ito, Marc Silverman, Alex Zamora, Sandhya Subramanian, Arthur A Vandenbark, Halina Offner.   

Abstract

To investigate regulatory mechanisms which naturally prevent autoimmune diseases, we adopted the genetically restricted immunodeficient (RAG-1(-/-)) myelin basic protein (MBP)-specific T cell receptor (TCR) double transgenic (T/R-) mouse model of spontaneous experimental autoimmune encephalomyelitis (Sp-EAE). Sp-EAE can be prevented after transfer of CD4+splenocytes from naïve immunocompetent mice. RAG-1+ double transgenic (T/R+) mice do not develop Sp-EAE due to the presence of a very small population (about 2%) of non-Tg TCR specificities. In this study, CD4+BV8S2+ T cells that predominate in T/R+ mice, and three additional populations, CD4+BV8S2-, CD4-CD8-BV8S2+, and CD4-CD8+BV8S2+ T cells that expanded in T/R+ mice after immunization with MBP-Ac1-11 peptide, were studied for their ability to prevent Sp-EAE in T/R- mice. Only the CD4+BV8S2- T cell population conferred complete protection against Sp-EAE, similar to unfractionated splenocytes from non-Tg donors, whereas CD4-CD8-BV8S2+ and CD4+BV8S2+ T cells conferred partial protection. In contrast, CD4-CD8+BV8S2+ T cells had no significant protective effects. The highly protective CD4+BV8S2- subpopulation was CD25+, contained non-clonotypic T cells, and uniquely expressed the CCR4 chemokine receptor. Protected recipient T/R- mice had marked increases in CD4+CD25+ Treg-like cells, retention of the pathogenic T cell phenotype in the spleen, and markedly reduced inflammation in CNS tissue. Partially protective CD4+BV8S2+ and CD4- CD8-BV8S2+ subpopulations appeared to be mainly clonotypic T cells with altered functional properties. These three Sp-EAE protective T cell subpopulations possessed distinctive properties and induced a variety of effects in T/R- recipients, thus implicating differing mechanisms of protection. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12478617     DOI: 10.1002/jnr.10450

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?

Authors:  Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2008-09       Impact factor: 7.397

2.  Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells.

Authors:  Thaís Boccia da Costa; Luiz R Sardinha; Rafael Larocca; Jean P S Peron; Luiz V Rizzo
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

3.  Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.

Authors:  Hong Dai; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-02-25       Impact factor: 3.478

Review 4.  Experimental models of spontaneous autoimmune disease in the central nervous system.

Authors:  Gurumoorthy Krishnamoorthy; Andreas Holz; Hartmut Wekerle
Journal:  J Mol Med (Berl)       Date:  2007-06-14       Impact factor: 4.599

5.  Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.

Authors:  Junping Xin; Derek A Wainwright; Craig J Serpe; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2007-11-19       Impact factor: 7.217

6.  Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.

Authors:  Asmita Pradeep Yeola; Prenitha Mercy Ignatius Arokia Doss; Joanie Baillargeon; Irshad Akbar; Benoit Mailhot; Mohammad Balood; Sébastien Talbot; Ana Carrizosa Anderson; Steve Lacroix; Manu Rangachari
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

Review 7.  Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease.

Authors:  Agata Matejuk; Arthur A Vandenbark; Halina Offner
Journal:  Front Neurol       Date:  2021-05-31       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.